A comparative clinical study of two Ayurvedic drugs on Intelligence Quotient of school going children with Borderline Intelligence

An Open Label Randomized Comparative Clinical study of Mandookaparni and Yastimadhu on Intelligence Quotient (IQ) of school going children with Borderline Intelligence

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/08/027188

Enrollment

100

Registered

2020-08-17

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F70- Mild intellectual disabilities

Interventions

Intervention1: Mandookaparni Vati: Group A will be given with Mandookaparni Vati with a dose of 250Mg, 1 tab twice daily after food for 12 Weeks Control Intervention1: Yastimadhu Vati: Group B will be

Eligibility

Inclusion criteria

Inclusion criteria: 1) Children between the ages of 11 to 13 years 2) Irrespective of sex, caste and religion 3) With IQ ranging from 70-79

Exclusion criteria

Exclusion criteria: 1) Children with developmental disorders like ADHD, autism and mental retardation 2) Children suffering from any acute, chronic infectious, systemic disorders and on treatment 3) Congenital abnormalities, genetic disorders, malnutrition

Design outcomes

Primary

Measure	Time frame
Improvement In Intelligence Quotient IQ assessment by Wechsler intelligence scale for children fourth editionTimepoint: 12 weeks	—

Secondary

Measure	Time frame
Parents and Teachers feedback with the help of questionnaires Performance in term testsTimepoint: 12weeks	—

Countries

India

Contacts

Public ContactDr Shine S Nair

Parul Institute of Ayurveda and Research

rajanishsm@gmail.com9986660145

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026